The study demonstrated that CNPY2 deletion protects against diethylnitrosamine-induced HCC in a mouse model, and analysis of human HCC samples revealed that higher CNPY2 expression is associated with worse survival outcomes [7]. This evidence concerns the gene CNPY2 and hepatocellular carcinoma.